Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06859710
PHASE1

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

The purpose of this research is to assess the impact of CBD on the effects of THC.

Official title: Interactions Between Delta-9-THC and CBD: A Controlled Human Drug-administration Study Probing a Harm Reduction Strategy

Key Details

Gender

All

Age Range

21 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-11-05

Completion Date

2028-09-01

Last Updated

2025-12-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Placebo

Vaporized Placebo

DRUG

THC

Vaporized THC (20 mg)

DRUG

CBD 20 mg

Vaporized CBD (20 mg)

DRUG

CBD 40 mg

Vaporized CBD (40 mg)

DRUG

CBD 80 mg

Vaporized CBD (80 mg)

Locations (1)

UCLA Center for Cannabis and Cannabinoids

Los Angeles, California, United States